Xuejing Yu, Dongchuan Ran, Jinhui Wang, et al. Unclear but present danger: An asymptomatic SARS-CoV-2 carrier. [J]. Genes & Diseases 7(4).(2020)
DOI:
Xuejing Yu, Dongchuan Ran, Jinhui Wang, et al. Unclear but present danger: An asymptomatic SARS-CoV-2 carrier. [J]. Genes & Diseases 7(4).(2020) DOI: 10.1016/j.gendis.2020.07.010.
Unclear but present danger: An asymptomatic SARS-CoV-2 carrier
摘要
Abstract
Superspreaders are critical infectious resources in multiple infectious diseases. They can be asymptomatic or present mild symptoms but can transmit pathogens to susceptible populations
leading to severe symptoms
and even death. Early identification of this population is extremely important to inhibit the spread of infectious diseases. Right now
the whole global world is suffering from a devastating infectious disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). In this article
a superspreader cluster event in coronavirus disease 2019 (COVID-19) was identified by tracking contacting histories of infected patients. This cluster was found to be originated from an asymptomatic SARS-CoV-2 carrier
which resulted in 13 secondary cases getting infected. All the secondary patients presented with non-typical symptoms of COVID-19
such as fever
dry cough
and myalgia
one of which died of respiratory failure at the end. From this cluster
we learn that people with older ages
low immunity
multiple underlying diseases
especially pulmonary diseases
can contribute to a poor prognosis. Thus
asymptomatic superspreaders of COVID-19 can be extremely dangerous and must be handled time-efficiently.
COVID-19 therapeutics: Clinical application of repurposed drugs and futuristic strategies for target-based drug discovery
Advances of CRISPR-Cas13 system in COVID-19 diagnosis and treatment
Single-cell transcriptome landscape and antigen receptor dynamic during SARS-CoV-2 vaccination
Reduced neutralization of SARS-CoV-2 B.1.617 variant by convalescent and vaccinated sera
Pandemic COVID-19: Current status and challenges of antiviral therapies
Related Author
Sunny Kumar
Malini Basu
Pratyasha Ghosh
Uttam Pal
Mrinal K. Ghosh
Qianqian Zhou
Yanhua Chen
Ruolei Wang
Related Institution
Department of Microbiology, Dhruba Chand Halder College, Dakshin Barasat, West Bengal
Cancer Biology and Inflammatory Disorder Division, Council of Scientific and Industrial Research-Indian Institute of Chemical Biology (CSIR-IICB), TRUE Campus, CN-6, Sector–V, Salt Lake, Kolkata-700091 & 4, Raja S.C. Mullick Road, Jadavpur, Kolkata
Department of Economics, Bethune College, University of Calcutta, Kolkata
Academy of Integrative Medicine, Shanghai University of Traditional Chinese Medicine
Bio-Medical College, Huazhong Agricultural University